Treatment of Neuromyelitis Optica

Update item information
Identifier 20130211_nanos_neuroopthaltreatmentsympos_03-2
Title Treatment of Neuromyelitis Optica
Creator Jeffrey L. Bennett, MD, Gertrude Gilden Professor of Neurology and Ophthalmology, University of Colorado
Subject Neuromyelitis Optica; Optic Neuritis; Plasma Exchange; Aquaporin-4; Complement-Mediated Cytotoxicity
Description Neuromyelitis optica (NMO) is an inflammatory disorder of the central nervous system (CNS) that primarily affects the optic nerves and spinal cord. Recent research has indicated that NMO is a distinct disorder form multiple sclerosis, where CNS injury is driven by an autoimmune antibody response against aquaporin-4 (AQP4) localized on astrocyte foot processes. Due to significant risk for permanent neurologic impairment, rapid diagnosis and appropriate therapy are essential. This presentation will examine current treatment paradigms in NMO and address novel directions for future therapy.
Relation is Part of NANOS 2013: Treatment in Neuro-Ophthalmology - That's Hot!
Contributor Primary Galetta, Steven
Contributor Secondary Quiros, Peter A
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2013-02-11
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection:
Type Image/MovingImage
Format video/mp4
Format Creation application/video
Source 2013 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2013. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL
Language eng
ARK ark:/87278/s6np5b61
Setname ehsl_novel_nam
ID 184428
Reference URL
Back to Search Results